CD30 is a crucial marker in distinguishing ALK-positive ALCL, typically showing diffuse CD30 expression from ALK-positive LBCL, which is CD30-negative or only weakly positive [88]. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.